Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02406625
Other study ID # DBT001
Secondary ID
Status Completed
Phase N/A
First received March 19, 2015
Last updated February 16, 2017
Start date November 2014
Est. completion date February 2017

Study information

Verified date February 2017
Source Fundacion Clinic per a la Recerca Biomédica
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Suicidal behaviors among adolescents represents a public health problem due to its high prevalence and its low predictability. It is also known that brain development continues during adolescence, therefore, a therapeutic intervention during this period might propitiate neural changes that might favor the emotional regulation involved in suicidal behaviors. Dialectical Behavioral Therapy has proved to be effective regarding this problem.

For this reason, the investigators aimed to study the clinical, neuropsychological and neural effects of Dialectical Behavioral Therapy in adolescents with suicidal behaviors.


Description:

Suicidal behaviors represent a public health problem due to its high prevalence and its low predictability. At a neurological level, higher vulnerability for suicidal behavior has been related to a frontostriatal-cingulum tract dysfunction as well as attention, memory and executive deficits. It is also known that brain development continues during adolescence, therefore, a therapeutic intervention during this period might propitiate neural changes that could favor the emotional regulation involved in suicidal behaviors. Specifically, Dialectical Behavioral Therapy has proved to be effective regarding this problem.

The investigators hypothesis is that DBT (Dialectical Behavioral Therapy) will improve clinical symptoms associated with suicidal behaviors, as well as the neural interconnections, which will result not only in structural and functional connectivity changes, but also in a better cognitive functioning. The investigators aimed to investigate the clinical, neuropsychological, and neural effects of Dialectical Behavioral Therapy in adolescents with suicidal behaviors.

The investigators method is a randomized, controlled study that includes 30 patients with suicidal behaviors and 15 healthy controls between the ages of 12 and 18 years. Patients were assigned to one of two groups (randomized): DBT and Regular Support Therapy. Clinical and neuropsychological evaluations were performed before and after the treatment for both patient groups. Additionally, Structural MRI data sets, diffusion-tensor imaging (DTI) and Functional Connectivity (Resting State fmri) were acquired for all patients and controls at baseline and after treatment. Initial characteristics will be compared between the three groups, and the investigators will also compared clinical, neuropsychological and imaging measures before and after the treatment.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date February 2017
Est. primary completion date February 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Years to 18 Years
Eligibility Inclusion Criteria:

- Age between 12 and 18 years,

- Intellectual level over 70 (IQ>70)

- For the experimental groups:

- Patients with suicidal behavior:

- Real attempt,

- Interrupted attempt,

- Aborted attempt or behaviors, or

- Preparation actions (based on the Columbia Suicide Severity Rating Scale -C-SSRS criteria) present during the last 12 months and that persist in the actual moment.

Exclusion Criteria:

- Presence of Acute Psychosis,

- Eating Disorder with an BMI < 18.5;

- Substance abuse in the current moment or during the last 6 months;

- Any neurological condition that curses with cognitive alterations; and

- Pregnancy.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Behavioral Therapy
16 therapeutic group sessions are delivered to both parents and adolescents; according to the assigned group for each family.

Locations

Country Name City State
Spain Hospital Clínic Barcelona

Sponsors (5)

Lead Sponsor Collaborator
Fundacion Clinic per a la Recerca Biomédica Font, Elena, Méndez Blanco, Iria, Romero Cela, María Soledad, Santamarina Pérez, Pilar

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical changes after 16 sessions of Dialectical Behavioral Therapy. Clinical evaluations will be performed before and after the treatment in order to determine clinical improvement in relation to the applied therapy. 4 months
Primary Neural changes after 16 sessions of Dialectical Behavioral Therapy. Magnetic Resonance Imaging and functional Magnetic Resonance Imaging data sets will be acquired at baseline and then after the treatment, in order to determine anatomical or functional brain connectivity changes in relation to the applied therapy. 4 months
Primary Neuropsychological changes after 16 sessions of Dialectical Behavioral Therapy. Neuropsychological evaluations will be administrated before and after the treatment in order to determine changes in memory, attention or executive functioning in relation to the applied therapy. 4 months
See also
  Status Clinical Trial Phase
Recruiting NCT04820946 - Evolution of DMDD Children and Adolescent
Completed NCT05127330 - Pilot RCT of a Video-based Intervention for Suicide Prevention N/A
Completed NCT04052477 - Social Web Mining for Suicide Prevention
Recruiting NCT06318962 - Examining the Efficacy of a Digital Therapeutic to Prevent Suicidal Behaviors N/A